G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $133,357 | -39.7% | 17,547 | -19.1% | 0.00% | – |
| Q4 2021 | $221,000 | -22.5% | 21,690 | +2.1% | 0.00% | – |
| Q3 2021 | $285,000 | -42.3% | 21,246 | -5.6% | 0.00% | – |
| Q2 2021 | $494,000 | +3.1% | 22,508 | +13.0% | 0.00% | – |
| Q1 2021 | $479,000 | +28.1% | 19,915 | -4.1% | 0.00% | – |
| Q4 2020 | $374,000 | +57.8% | 20,767 | +1.0% | 0.00% | – |
| Q3 2020 | $237,000 | -52.3% | 20,554 | 0.0% | 0.00% | – |
| Q2 2020 | $497,000 | +106.2% | 20,554 | -6.2% | 0.00% | – |
| Q1 2020 | $241,000 | -55.5% | 21,909 | +6.8% | 0.00% | -100.0% |
| Q4 2019 | $542,000 | -24.4% | 20,516 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $717,000 | +10.1% | 21,116 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $651,000 | -10.3% | 21,219 | +52.7% | 0.00% | 0.0% |
| Q3 2018 | $726,000 | +7.7% | 13,892 | -10.4% | 0.00% | 0.0% |
| Q2 2018 | $674,000 | +68.1% | 15,507 | +43.6% | 0.00% | – |
| Q1 2018 | $401,000 | +190.6% | 10,800 | +54.9% | 0.00% | – |
| Q4 2017 | $138,000 | -19.3% | 6,974 | +1.2% | 0.00% | – |
| Q3 2017 | $171,000 | – | 6,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |